The U.S. medical office building (MOB) market is a roughly $400 billion asset class, with institutional ownership concentrated in a small number of dedicated healthcare REITs and a longer tail of private fund sponsors. The investment thesis has held up through three credit cycles: tenant credit is anchored by health systems, large physician groups, and IPA networks; lease tenors run 7 to 15 years with regular escalators; tenant turnover is structurally low because medical fit-outs are expensive and clinical workflows are sticky. What the asset class has not had is a clean entry path for allocators outside the dedicated healthcare REIT channel and a handful of closed-end private funds.

Medical office building tokenization is starting to close that gap. In 2026, sponsors are issuing tokenized interests in single MOBs, on-campus and off-campus portfolios, and contracted lease cash flows under regulated private placement frameworks. The underlying economics — tenant credit, occupancy, rent escalators, capex reserves, debt service — are unchanged. The capital markets wrapper is what is new.

What a Tokenized MOB Position Represents

A tokenized MOB interest is a regulated security that gives fractional economic exposure to a specific medical office property, a portfolio of healthcare-anchored buildings, or a contracted lease cash flow stream. Institutional issuance sits under Reg D 506(c), Reg S, and Reg A+ in the U.S., with transfer restrictions, accreditation gating, and jurisdiction-based eligibility enforced at the protocol level.

Three structures are emerging:

• Single-asset tokenization. A specific on-campus or off-campus MOB, typically with a credit-tenant anchor and a 10- to 15-year primary lease in place, is held in an SPV and tokenized. Investors hold equity or preferred interests with distributions tied to net operating income after debt service and reserves.
• Portfolio tokenization. A sponsor consolidates multiple geographically diversified MOBs — Sun Belt growth markets, secondary metros with strong health system positioning, on-campus assets tied to integrated delivery networks — into a single tokenized vehicle. Diversification across health system counterparties, payer mix exposure, and metro fundamentals smooths distributions.
• Lease cash flow tokenization. Specific contracted revenue streams — long-dated triple-net leases to investment-grade health systems — are tokenized as fixed-income-style instruments. These behave like single-tenant net lease bonds and are increasingly suitable for insurance balance sheets that need credit-tenant duration.

In every structure, the token is a security under U.S. federal and state law. Classification dictates investor eligibility, transfer restrictions, holding periods, and reporting obligations.

Why Healthcare Real Estate Is Pulling Tokenization Forward

Three forces are driving institutional issuance through 2026.

Demographic demand is structurally accelerating. The 65-and-over population in the U.S. is on pace to reach roughly 73 million by 2030, and ambulatory care has been the single largest category of healthcare delivery growth for the past decade as health systems shift volume out of inpatient settings. That migration translates directly into MOB demand, particularly for off-campus locations near population centers. Allocators who underwrite this demographic profile want exposure beyond the public REIT path, and tokenization opens up direct interest issuance without forcing them through a 10-year closed-end fund.

Health system credit has held up through cycle stress. Investment-grade health system tenants weathered the 2022 to 2024 operating margin compression with rating affirmations and rare downgrades among the largest IDNs. For credit-focused allocators, MOB exposure backed by an A-rated health system anchor is functionally a long-dated corporate credit instrument with real estate residual value underneath. Tokenized lease cash flow structures isolate that credit profile cleanly, which is exactly what insurance ALM teams have been asking for.

Compliant secondary venues are compressing the illiquidity discount. MOB interests held in private funds historically traded at a 150 to 300 basis point illiquidity discount versus comparable listed healthcare REIT exposure. Reg ATS-licensed venues for tokenized securities give qualified investors a path to exit positions without a fund-level redemption event. That secondary path does not turn medical office into a liquid asset, and it should not. It does close part of the structural discount that has held back direct private allocations.

For more on how secondary liquidity is changing institutional appetite for real asset structures, see our analysis of tokenized real-world asset markets.

What Compliance Looks Like for a Tokenized MOB Issuance

The regulatory frame is the same one that applies to any institutional private placement, with additional layers for the digital instrument and for healthcare-specific operational considerations.

The instrument itself is a security. Sponsors with on-campus assets need to confirm that the underlying ground lease or facility services agreement with the health system permits the issuance structure. Some legacy ground leases include change-of-control provisions or assignment restrictions that have to be cleared before the tokenization layer goes live. This is a paper diligence question, not a blockchain question, but the better issuance platforms surface it during structuring rather than at closing.

Investor onboarding has to handle KYC, AML, accreditation verification, and sanctions screening at the protocol level. Transfer restrictions must be enforced on-chain, so a token cannot move to a wallet that has not cleared compliance review. For non-U.S. allocators participating under Reg S, the platform has to enforce U.S. flow-back restrictions during the distribution compliance period.

Fund administration is where most retail-oriented platforms break down. An institutional allocator needs audited NAV, capital account statements, K-1s or PFIC reports depending on structure, property-level operating reports, tenant credit monitoring, and outputs that an institutional auditor can sign. Medical office in particular has accounting nuances — TI amortization across long primary lease terms, capex reserve treatment for clinical fit-outs, percentage rent on imaging or surgical center components — that a generic tokenization platform will not handle.

Custody and integration with qualified fund administrators are the operational pinch points. Sponsors should not be migrating their entire back office to access tokenized issuance. The platform has to fit into the existing operating stack alongside the property manager, the leasing agent, and the financing parties.

For a closer look at the compliance architecture institutional issuers are evaluating, see our note on compliance-first tokenization infrastructure.

What Fund Managers Should Underwrite Before Allocating

Tokenization does not change healthcare real estate diligence. It adds three layers on top of it.

The underlying MOB still has to clear traditional underwriting. Health system anchor credit, lease tenor, escalator structure, on-campus versus off-campus positioning, payer mix exposure, market share of the anchor system, building functionality for current clinical use, and reversionary risk all matter. A tokenized MOB with a non-investment-grade anchor and a 4-year remaining primary term is still a stressed asset. The wrapper does not improve the credit.

The capital stack has to be legally clean. Where does the tokenized interest sit relative to property debt and any preferred equity? What are the cash sweep mechanics, and what triggers them? How are TI and capex reserves funded across lease renewals? What happens to distributions if the anchor exercises an early termination right? These questions need to be answered in the offering documents, not assumed.

Operational governance has to hold up. Who makes decisions about lease renewals, capital improvements, refinancing, or asset sale? What are the rights of token holders versus the SPV? What happens to the tokenized interest if the property is sold, recapitalized, or the sponsor is replaced? Institutional allocators expect governance terms that look more like LPA negotiated terms than retail offering language, and the better issuance platforms are converging on that standard.

The opportunity in 2026 is not that tokenization improves a marginal MOB. It is that tokenization gives institutional capital a cleaner, compliant path into healthcare real estate cash flows without the structural drag of a closed-end fund wrapper or the equity beta of a listed healthcare REIT.

What Comes Next

The next 18 months will be shaped by three trends. First, more healthcare REITs and private fund sponsors will tokenize stabilized portfolios to recycle capital out of mature assets and back into development and acquisition pipelines. Second, insurance and pension allocators will move from pilot positions to programmatic healthcare real estate mandates, and platform selection will turn on compliance posture and reporting depth, not headline yield. Third, tokenized lease cash flow instruments anchored by investment-grade health system tenants will compete directly with single-tenant net lease bond structures for institutional fixed income allocations.

For fund managers evaluating MOB tokenization structures or building a healthcare real estate mandate, Commertize provides the compliance-first issuance and capital markets infrastructure institutional managers are using to bring regulated real-world assets on-chain. Reach out through our contact page to discuss specific mandates.

Have an asset you're evaluating for tokenization? Send the offering memo to deals@commertize.com or start at commertize.com/tokenize, and we will return a written tokenizability and capital-structure memo within 48 hours — free, no obligation.

Confidential review. No cost, no commitment, no calls unless it is a fit.